RE: Valuation?10 May 2018 16:16
So have they cancelled the Japanese study since its wasted money.. Hell no..
Japanese partner Maruishi continued to progress their pivotal Phase III ARDS trial in Japan and has received two IDMC recommendations to continue the trial as planned. Maruishi anticipates completion of recruitment of this 120-patient study in mid 2018.